Kolexia
Saraux Alain
Rhumatologie
Hôpital Cavale Blanche
Brest, France
601 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Arthrite Polyarthrite rhumatoïde Syndrome de Gougerot-Sjögren Spondylarthrite Rhumatisme inflammatoire des ceintures Spondyloarthrite axiale Rhumatismes Pelvispondylite rhumatismale Spondylite

Industries

Abbvie
25 collaboration(s)
Dernière en 2023
Lilly
13 collaboration(s)
Dernière en 2023
Edimark
12 collaboration(s)
Dernière en 2022
Novartis
12 collaboration(s)
Dernière en 2023

Dernières activités

Characterisation of airway disease associated with Sjögren disease.
RMD open   29 février 2024
Impact of the time of initiation and line of biologic therapy on the retention rate of secukinumab in axial spondyloarthritis (axSpA): data from the French multicentre retrospective FORSYA study.
RMD open   29 février 2024
Reliability Exercise of Ultrasound Salivary Glands in Sjögren's Disease: An International Web Training Initiative.
Rheumatology and therapy   19 février 2024
Reply.
Arthritis & rheumatology (Hoboken, N.J.)   07 février 2024
Abatacept in early polymyalgia rheumatica (ALORS): a proof-of-concept, randomised, placebo-controlled, parallel-group trial.
The Lancet. Rheumatology   22 janvier 2024
PSSIT: Phase II/III Double-blind Randomized Placebo-controlled Trial Assessing the Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk in Subjects With Specific Dysimmunity and Raynaud Phenomenon
Essai Clinique (CHU Bordeaux)   18 janvier 2024
Impact of the COVID-19 Pandemic on People Living with Rheumatoid Arthritis: Experiences and Preferences in Accessing Healthcare Across Five Countries.
Rheumatology and therapy   13 janvier 2024
Ten-Year Clinical Outcome of recent-onset Axial Spondyloarthritis: results from the DESIR inception Cohort.
Joint bone spine   30 décembre 2023
Combined anti-Ro52/TRIM21 and anti-Ro60/SSA antibodies are associated with increased Sjögren's disease severity through interferon pathway activation.
Arthritis & rheumatology (Hoboken, N.J.)   21 décembre 2023
Syndrome VEXAS : description clinique et options thérapeutiques
Edimark   18 décembre 2023